Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLoCaMB
NCT03386201Unknown
- Sponsor
- University of Oxford
- Start
- Jan 2018
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of methylene blue in bile duct injury (BDI), sponsored by University of Oxford. Primary endpoint: Concordance of surgeon anatomy definition with fluorescence outline. Status: unknown.
02
Drugs
methylene blue
03
Conditions
bile duct injury (BDI)
Beyond the preview
Go deeper on NCT03386201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03386201.